Literature DB >> 20142454

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Barbara J Drew, Michael J Ackerman, Marjorie Funk, W Brian Gibler, Paul Kligfield, Venu Menon, George J Philippides, Dan M Roden, Wojciech Zareba.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20142454      PMCID： PMC3056123          DOI： 10.1161/CIRCULATIONAHA.109.192704

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  114 in total

Review 1.  How to correct the QT interval for the effects of heart rate in clinical studies.

Authors:  Patrick Davey
Journal:  J Pharmacol Toxicol Methods       Date:  2002 Jul-Aug       Impact factor: 1.950

2.  Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one.

Authors:  Sami Viskin; Uri Rosovski; Andrew J Sands; Edmond Chen; Peter M Kistler; Jonathan M Kalman; Laura Rodriguez Chavez; Pedro Iturralde Torres; Fernando E S Cruz F; Osmar A Centurión; Akira Fujiki; Philippe Maury; Xiaomin Chen; Andrew D Krahn; Franz Roithinger; Li Zhang; G Michael Vincent; David Zeltser
Journal:  Heart Rhythm       Date:  2005-06       Impact factor: 6.343

Review 3.  Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.

Authors:  Luc M Hondeghem
Journal:  J Cardiovasc Electrophysiol       Date:  2006-03

Review 4.  Clinical safety profile of sotalol in patients with arrhythmias.

Authors:  L F Soyka; C Wirtz; R B Spangenberg
Journal:  Am J Cardiol       Date:  1990-01-02       Impact factor: 2.778

5.  Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.

Authors:  Henriette Sloth Pedersen; Hanne Elming; Marie Seibaek; Hans Burchardt; Bente Brendorp; Christian Torp-Pedersen; Lars Køber
Journal:  Am J Cardiol       Date:  2007-06-27       Impact factor: 2.778

Review 6.  Early after-depolarizations and torsade de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization.

Authors:  D M Roden
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

7.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

Authors:  J W Mason; L M Hondeghem; B G Katzung
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

Review 8.  What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers.

Authors:  Sergio L Pinski; Luis E Eguía; Richard G Trohman
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

9.  Mechanism of the cardiotoxic actions of terfenadine.

Authors:  R L Woosley; Y Chen; J P Freiman; R A Gillis
Journal:  JAMA       Date:  1993 Mar 24-31       Impact factor: 56.272

Review 10.  QTc interval in the assessment of cardiac risk.

Authors:  Hanne Elming; Bente Brendorp; Lars Køber; Najia Sahebzadah; Christian Torp-Petersen
Journal:  Card Electrophysiol Rev       Date:  2002-09
View more
  155 in total

1.  Static and Dynamic Electrocardiographic Patterns Preceding Torsades de Pointes in the Acquired and Congenital Long QT Syndrome.

Authors:  Jp Couderc; J Xia; X Xu; S Kaab; M Hinteeser; W Zareba
Journal:  Comput Cardiol (2010)       Date:  2010-09-26

2.  Considerations on safety concerns about citalopram prescribing.

Authors:  Robert D Sheeler; Michael J Ackerman; Elliott Richelson; Thomas K Nelson; Jeffrey P Staab; Eric G Tangalos; Lisa M Dieser; Julie L Cunningham
Journal:  Mayo Clin Proc       Date:  2012-09-24       Impact factor: 7.616

Review 3.  Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies.

Authors:  Rezarta Cuni; Iris Parrini; Riccardo Asteggiano; Maria Rosa Conte
Journal:  Clin Drug Investig       Date:  2017-02       Impact factor: 2.859

4.  Overdrive pacing in a patient with incessant torsades de pointes.

Authors:  Adam N Overbey; Andrea Austin; Daniel F Seidensticker; Andrew H Lin
Journal:  BMJ Case Rep       Date:  2013-10-11

5.  [Not Available].

Authors:  K Onsea; M Coosemans
Journal:  Neth Heart J       Date:  2011-05       Impact factor: 2.380

6.  Phenotype of Children with QT Prolongation Identified Using an Institution-Wide QT Alert System.

Authors:  Heather N Anderson; J Martijn Bos; Kristina H Haugaa; Bruce W Morlan; Robert F Tarrell; Pedro J Caraballo; Michael J Ackerman
Journal:  Pediatr Cardiol       Date:  2015-04-07       Impact factor: 1.655

Review 7.  Simplifying QT prolongation for busy clinicians.

Authors:  Kelly A Grindrod; Jeff Nagge
Journal:  Can Fam Physician       Date:  2019-04       Impact factor: 3.275

8.  Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.

Authors:  Francis Bessière; Hugo Roccia; Antoine Delinière; Rome Charrière; Philippe Chevalier; Laurent Argaud; Martin Cour
Journal:  JAMA Cardiol       Date:  2020-09-01       Impact factor: 14.676

9.  Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.

Authors:  Niyada Naksuk; Alan M Sugrue; Deepak Padmanabhan; Danesh Kella; Christopher V DeSimone; Suraj Kapa; Samuel J Asirvatham; Hon-Chi Lee; Michael J Ackerman; Peter A Noseworthy
Journal:  J Interv Card Electrophysiol       Date:  2018-10-23       Impact factor: 1.900

10.  Pro- and antiarrhythmic effects of ATP-sensitive potassium current activation on reentry during early afterdepolarization-mediated arrhythmias.

Authors:  Marvin G Chang; Enno de Lange; Guillaume Calmettes; Alan Garfinkel; Zhilin Qu; James N Weiss
Journal:  Heart Rhythm       Date:  2012-12-12       Impact factor: 6.343
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.